Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma

IMPORTANCE: Melanoma treatment has evolved during the past decade with the adoption of adjuvant and palliative immunotherapy and targeted therapies, with an unclear impact on health care costs and outcomes in routine practice. OBJECTIVE: To examine changes in health care costs, overall survival (OS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bateni, Sarah B., Nguyen, Paul, Eskander, Antoine, Seung, Soo Jin, Mittmann, Nicole, Jalink, Matthew, Gupta, Arjun, Chan, Kelvin K. W., Look Hong, Nicole J., Hanna, Timothy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483386/
https://www.ncbi.nlm.nih.gov/pubmed/37672282
http://dx.doi.org/10.1001/jamadermatol.2023.3179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483386/
https://www.ncbi.nlm.nih.gov/pubmed/37672282
http://dx.doi.org/10.1001/jamadermatol.2023.3179

Ejemplares similares